Comparative evaluation of two different Artemisia dracunculus L. Cultivars for blood sugar lowering effects in rats

Phytotherapy Research

Volumn 26, Issue 4, 2012, Pages 625-629

  Weinoehrl, Stefanie ^a,d   Feistel, Bjoern ^b   Pischel, Ivo ^c   Kopp, Brigitte ^d   Butterweck, Veronika ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b Plantextrakt GmbH and Co KG   (Germany)

^c PhytoLab GmbH   (Germany)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

antidiabetic; aqueous extract; Artemisia dracunculus; estragole; ethanol extract; methyleugenol

Indexed keywords

ALCOHOL; ESTRAGOLE; GLIBENCLAMIDE; GLUCOSE; INSULIN; METHYLEUGENOL; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTEMISIA DRACUNCULUS; ARTICLE; CONTROLLED STUDY; CULTIVAR; DRUG ISOLATION; DRUG STRUCTURE; FUNCTIONAL FOOD; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PHYTOCHEMISTRY; PROCESS DEVELOPMENT; RAT; SOLVENT EXTRACTION; SPECIES COMPARISON;

ANIMALS; ANISOLES; ARTEMISIA; BLOOD GLUCOSE; CHEMICAL FRACTIONATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; ETHANOL; EUGENOL; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; SPECIES SPECIFICITY; WATER;

ARTEMISIA; ARTEMISIA DRACUNCULUS; RATTUS;

EID: 84859580390     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3605     Document Type: Article

References (15)

1. Bundesinstitut fuer gesundheitlichen Verbrauerschutz und Veterinaemedizin BgVV. 2001. Estragol- und Methyleugenolgehalte in teeaehnlichen Erzeugnissen. Statement of the BgVV November 12 2001. Available from
2. Cefalu WT, Ye J, Zuberi A, et al,. 2008. Botanicals and the metabolic syndrome. Am J Clin Nutr 87: 481S-487S.
3. De Vincenzi M, Silano M, Maialetti F, Scazzocchio B,. 2000. Constituents of aromatic plants: II. Estragole. Fitoterapia 71: 725-729.
4. EMEA. 2004. EMEA Working Party on Herbal Medicinal Products: Final position paper on the use of herbal medicinal products containing estragole. Available from
5. European Pharmacopoeia 7th version. 2011. Monograph: Hawthorn Leaf And Flower Dry Extract. Council of Europe: Strassbourg; 1149-1150.
6. Govorko D, Logendra S, Wang Y, et al,. 2007. Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line. Am J Physiol 293: E1503-E1510.
7. Haeusel R, Keller K, Rimpler N, (eds). 1992. Artemisia. In Hagers Handbuch der Pharmazeutischen Praxis, 5th edn, Vol. 4. Drogen A-D. Springer Publisher: Berlin; 357-377.
8. Logendra S, Ribnicky DM, Yang H, et al,. 2006. Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus. Phytochemistry 67: 1539-1546.
9. Ribnicky DM, Kuhn P, Poulev A, et al,. 2009. Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L. Int J Pharm 370: 87-92.
10. Ribnicky DM, Poulev A, O'Neal J, et al,. 2004. Toxicological evaluation of the ethanolic extract of Artemisia dracunculus L. for use as a dietary supplement and in functional foods. Food Chem Toxicol 42: 585-598.
11. Ribnicky DM, Poulev A, Watford M, Cefalu WT, Raskin I,. 2006. Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 13: 550-557.
12. Smith RL, Adams TB, Doull J, et al,. 2002. Safety assessment of allylalkoxybenzene derivatives used as flavouring substances-methyl eugenol and estragole. Food Chem Toxicol 40: 851-870.
13. Teuscher E,. 2003. Monographie Estragon. In Gewuerzdrogen. Wissenschaftliche Verlagsgesellschaft: Stuttgart, 121-123.
14. Vienne M, Braemer R, Paris M, Couderc H,. 1989. Chemotaxonomic study of two cultivars of Artemisia dracunculus L.: ('French' and 'Russian' tarragon). Biochem Syst Ecol 17: 373-374.
15. Wang ZQ, Ribnicky D, Zhang XH, Raskin I, Yu Y, Cefalu WT,. 2008. Bioactives of Artemisia dracunculus L. enhance cellular insulin signaling in primary human skeletal muscle culture. Metabolism 57: S58-S64.